Erythrocyte pathology clearly indicates microcirculatory problems [208, 230, 232, 375], supporting the hypothesis that inadequate microcirculation in Long COVID, leading to ischemia-reperfusion injury, could play a critical role [352]
Clinical Trials: Studies have shown that patients receiving BPC-157 therapy experience significant improvements in pain and function
It was first characterised in preclinical research for its cytoprotective properties and has since accumulated over 100 peer-reviewed publications across gastroenterology, orthopaedics, and regenerative biology.1 What makes BPC-157 unusual is structural stability
Margolina, The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health, Hindawi Limited, 2012